贵州三力(603439) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 reached ¥526,888,368.01, an increase of 55.50% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was ¥77,072,340.14, reflecting a growth of 35.17% year-on-year[2] - Year-to-date net profit attributable to shareholders reached ¥194,132,141.59, up 22.89% from the previous year[2] - Basic earnings per share for Q3 2024 was ¥0.18, an increase of 28.57% compared to the same period last year[3] - The diluted earnings per share for Q3 2024 was also ¥0.18, reflecting a 28.57% increase year-on-year[3] - Total operating revenue for the first three quarters of 2024 reached CNY 1,447,114,245.43, a significant increase from CNY 969,505,205.34 in the same period of 2023, representing a growth of approximately 49.2%[15] - Net profit for the first three quarters of 2024 was CNY 198,783,556.37, compared to CNY 157,480,116.98 in 2023, reflecting a growth of approximately 26.2%[16] - The total comprehensive income for the first three quarters of 2024 was CNY 198,783,556.37, up from CNY 157,480,116.98 in 2023, indicating a growth of about 26.2%[16] Assets and Liabilities - Total assets as of the end of Q3 2024 amounted to ¥3,058,607,480.44, representing a 4.73% increase from the end of the previous year[3] - The company's total liabilities amount to approximately ¥845.71 million, slightly up from ¥839.01 million, indicating a marginal increase[13] - The company's total liabilities amounted to CNY 1,200,910,582.62, slightly down from CNY 1,211,097,697.17 in the previous year[14] - The total equity attributable to shareholders of the parent company increased to CNY 1,602,666,108.48 from CNY 1,470,311,172.51, marking an increase of about 8.9%[14] Cash Flow - The company reported a 51.10% decrease in cash flow from operating activities year-to-date, totaling ¥88,961,699.77[2] - Total cash inflow from operating activities for the first three quarters of 2024 was approximately 1.48 billion RMB, up from 1.07 billion RMB in the same period of 2023, an increase of 37.68%[17] - Net cash flow from operating activities decreased to approximately 88.96 million RMB in 2024 from 181.94 million RMB in 2023, a decline of 51.06%[17] - Cash inflow from investment activities for the first three quarters of 2024 was approximately 85.56 million RMB, down from 168.08 million RMB in 2023, a decrease of 49.05%[18] - Net cash flow from investment activities showed a negative balance of approximately 67.28 million RMB in 2024 compared to a negative 159.26 million RMB in 2023, an improvement of 57.77%[18] - Cash inflow from financing activities increased to approximately 204.20 million RMB in 2024 from 85.00 million RMB in 2023, a significant increase of 140.24%[18] - The company reported a net cash outflow from financing activities of approximately 55.75 million RMB in 2024, compared to a net outflow of 47.74 million RMB in 2023[18] - The ending balance of cash and cash equivalents as of Q3 2024 was approximately 537.30 million RMB, down from 545.77 million RMB in Q3 2023, a decrease of 1.63%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 25,117, with the largest shareholder holding 40.91% of the shares[8] - The top ten shareholders collectively hold 40.91% of the shares, with the largest individual shareholder owning 167,668,440 shares[10] - The company holds 9,420,200 shares in its repurchase account, representing 2.30% of the total share capital[11] - There are no significant changes in the shareholder structure or voting rights restoration for preferred shareholders during the reporting period[11] Operational Metrics - The increase in revenue and net profit is primarily attributed to sales growth and the consolidation of Hanfang Pharmaceutical[6] - The weighted average return on equity for Q3 2024 was 4.94%, an increase of 0.68 percentage points compared to the previous year[3] - Research and development expenses for the first three quarters of 2024 were CNY 29,839,167.47, compared to CNY 18,471,561.72 in 2023, showing an increase of approximately 61.7%[15] - The company reported a profit margin of approximately 13.7% for the first three quarters of 2024, compared to 16.2% in the same period of 2023[16] - The company's cash flow from operating activities was impacted by increased payments to employees, which rose to approximately 218.43 million RMB from 137.76 million RMB, an increase of 58.54%[17] Non-Recurring Items - Non-recurring gains and losses for the current period included government subsidies amounting to ¥2,581,496.59[4]